Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes, or a History of Stroke
J Am Soc Hypertens
.
2016 Jul:10 Suppl 1:e6-e7.
doi: 10.1016/j.jash.2016.06.020.
Authors
A Bress
1
,
R M Tanner
2
,
R Hess
3
,
S S Gidding
4
,
L D Colantonio
2
,
D Shimbo
5
,
P Muntner
2
Affiliations
1
Pharmacotherapy, University of Utah, Salt Lake City, UT.
2
Epidemiology, University of Alabama at Birmingham, Birmingham, AL.
3
Population Health Sciences, University of Utah, Salt Lake City, UT.
4
Nemours Cardiac Center, Alfred I. DuPont Hospital for Children, Salt Lake City, DE.
5
Medicine, Columbia University, New York, NY.
PMID:
27677143
DOI:
10.1016/j.jash.2016.06.020
No abstract available
Grants and funding
K24 HL125704/HL/NHLBI NIH HHS/United States